The role of metals in the enzymatic and nonenzymatic oxidation of epinephrine.
The effects of transition metals on nonenzymatic and ceruloplasmin catalyzed epinephrine oxidation were investigated by studying rates of epinephrine oxidation in purified buffers and in the presence of metal chelating agents. We found that epinephrine does not "autoxidize" in sodium chloride solutions prepared with deionized water that was further purified by chromatography over Chelex 100 resin prior to use. Epinephrine was oxidized rapidly in sodium chloride prepared with tap water (1.20 +/- 0.12 nmoles/min) or in deionized water (0.40 +/- 0.80 nmoles/min), but this oxidation was prevented by the addition of Desferal, a potent metal chelating agent. Epinephrine oxidation was enhanced upon the addition of ceruloplasmin, and this oxidation rate could be slowed, but not eliminated, by the addition of Desferal. If epinephrine solutions were preincubated for 72 hours with Desferal prior to ceruloplasmin addition, however, no oxidation was observed. Epinephrine was shown to form colored complexes with both iron and copper at pH 7.0. The Fe(III)-epinephrine complex was much more stable than was the Cu(II)-epinephrine complex. Oxygen consumption studies of ceruloplasmin catalyzed epinephrine oxidation showed that copper was a better promoter of epinephrine oxidation than was iron, suggesting that ceruloplasmin-catalyzed epinephrine oxidation results from adventitious copper bound to the purified enzyme. In light of these results, the physiological relevance of ceruloplasmin catalyzed oxidation of biogenic amines may be minor.
Ryan
T P
TP
Biotechnology Center, Utah State University, Logan 84322-4705.
Miller
D M
DM
Aust
S D
SD
D015306:Biogenic Monoamines / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D002570:Ceruloplasmin / Q000494:pharmacology; D003300:Copper / Q000494:pharmacology; D003676:Deferoxamine / Q000494:pharmacology; D004837:Epinephrine / Q000378:metabolism*; D006801:Humans; D007501:Iron / Q000494:pharmacology; D008670:Metals / Q000378:metabolism*; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects; D011048:Polarography; D013056:Spectrophotometry, Ultraviolet
D015306:Biogenic Monoamines; D002395:Catecholamines; D008670:Metals; D003300:Copper; D007501:Iron; D002570:Ceruloplasmin; D003676:Deferoxamine; D004837:Epinephrine